They kept the “specialty pharmacy” on the insurance side. Says it all. 💯 need to pass the legislation.
That’s pretty funny. He is a genius financial engineer. The split is great for shareholders. Changes nothing for patients or anyone who pays for insurance or care.
He is posturing to be able to say “See, we broke up our company. “. Don’t fall for it @HawleyMO @SenWarren
We need to pass the bill now more than ever
John Coler retweeted
Great move by @GovBillLee
As their CEO said "America has too many pharmacies "
John Coler retweeted
Oh no, our precious secret drug prices! 😱
statnews.com/2026/04/20/pbm-…
John Coler retweeted
PBMs say they want low list prices for drugs.
Their new affiliated private label drug companies now have the power to do it themselves.
Instead, the generic prices are on average 33 times higher than the lowest in the market.
@ikeswetlitz @jtozz bloomberg.com/news/articles/…
John Coler retweeted
BREAKING: @Commpharmacy leads 134 groups in letter urging Congress to pass PBM reform. Included are patient groups, labor groups, employer groups, and healthcare providers. Read more here:
bit.ly/3V9vw0z
Take a billion, pay back 290M (240) and they will still let me do business. Sounds familiar. Why would they stop?
Thankfully PBMs are not overcharging Ohio businesses…just the Federal Government right? @ohiobrt @OhioChamber @OhioPharmacists @Walgreens @NACDS @FTC @Walmart @kroger @cardinalhealth foxbusiness.com/retail/cvs-c…
11
466
John Coler retweeted
Ohio pharmacy is seriously declining and the problem is clear: pharmacy benefit managers are driving pharmacies out of business
For Ohio pharmacy to survive, we must fight back, and we must fight back together
We are stronger together. Join OPA today: ohiopharmacist.org/join
RiteAid closed in two of the communities we serve. An Independent pharmacy closed shortly after. Upside down claims are unsustainable for all. Access is collapsing.
Across America, remaining pharmacies are inheriting underpaying PBM contracts from closing pharmacies. The system will soon collapse. @OhioPharmacists @ipcrx @_APCI @OhioSenateGOP @OhioHRA @NACDS king5.com/video/news/local/r…
Ohio Legislature must act now to prevent an access crisis. The consequence will be to great to fix.
Why are Ohioans losing pharmacy access? It’s math. PBM @pcmanet math to be exact. @OhioPharmacists @NACDS @ipcrx @_APCI @kroger @meijer @FTC @Walmart @Walgreens ohiocapitaljournal.com/2025/…
The US Congress needs to quite talking for clicks and act on bi partisan PBM reform. There is no more excuses not to act.
Arkansas is relentless.
talkbusiness.net/2025/03/gov…
John Coler retweeted
Arkansas is relentless.
talkbusiness.net/2025/03/gov…
John Coler retweeted
Why are Ohio’s community pharmacies being used as scapegoats to increase the cost of hospital care by $2 Billion with no improvements in health quality or services?
Solution: allow community pharmacies to keep filling 340B prescriptions.
Patients need access where they live!
@OHRGOPCaucus @OhioSenateGOP @GovMikeDeWine @OhioPharmacists @gongwer @DispatchAlerts @OhioCapJournal
Thank you @RepBalderson for advocating for PBM reform for your constituents. Ohio lost 191 pharmacies in 2024 leaving more Ohioans without quick access to a local pharmacy.
The current PBM marketplace leaves patients worse off, creating pharmacy deserts that make it more difficult for patients to access medications @RepBalderson emphasizes.
Rep. Balderson's Questions
CMS decision to make pharmacies (not PBMs or Mfg)carry the financial burden of IRA drugs will hurt access and close more Independents. They know this.
Public policy can be tricky. Medicare's new push to negotiate the costs of brand drugs is no different.
Our new study shows that pharmacies will face new profitability and cash flow pressures that could undermine the policy's goal of improving access. 3axisadvisors.com/projects/2…
More access gone. I hope their patients join the fight for PBM reform.
Sad to hear that Schwieterman Pharmacies are closing in Ohio – truly one of the good ones wdtn.com/news/health/local-p…
CMS is creating a system that will put more pharmacies out of business and again hurt access when PBMs and Manufacturers should float the program. It’s beginning to look deliberate.
NCPA wants to make sure patients are getting the benefit of using MDPN program drugs, but we reiterate that pharmacies can’t afford to float this program. If @CMSGov doesn’t change course, the program will fail.
John Coler retweeted
NCPA wants to make sure patients are getting the benefit of using MDPN program drugs, but we reiterate that pharmacies can’t afford to float this program. If @CMSGov doesn’t change course, the program will fail.
Today, CMS announced the 15 drugs covered under Medicare Part D that were selected for the second round of the Medicare Drug Price Negotiation Program. See the full list here: cms.gov/newsroom/press-relea…
Exposed 6 years ago, now verified by FTC, when will our government act and protect access?
We launched @46brooklyndata in August 2018 with an exposé on how Medicaid programs were being overcharged for generic Gleevec by thousands of dollars per claim.
The FTC’s latest PBM report shows that was just the tip of the iceberg. @pharmalot statnews.com/pharmalot/2025/…
















